Brief: Werewolf Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Study Of WTX-330

Werewolf Therapeutics

24/02/2023 12:31

Feb 24 (Reuters) - Werewolf Therapeutics Inc  HOWL.O :
    * WEREWOLF THERAPEUTICS ANNOUNCES INITIATION OF PATIENT
DOSING IN
PHASE 1 STUDY OF WTX-330

Source text for Eikon:  ID:nGNXJQqHN 
Further company coverage:  HOWL.O 
 ((Reuters.Briefs@thomsonreuters.com;))